NinePointTwo Capital’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
GEH
ACM
NinePointTwo Capital's CDLX Position: Q4 2022 in Review
NinePointTwo Capital sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 3,088 shares — an estimated $290K sold.
NinePointTwo Capital first reported a position in CDLX in Q3 2022 and held it in 1 quarter. The position peaked at $290K in Q3 2022. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.
- NinePointTwo Capital reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
- NinePointTwo Capital sold 3,088 Cardlytics shares in Q4 2022, an estimated $290K.
- NinePointTwo Capital first reported a position in Cardlytics in Q3 2022 and held it in 1 quarter.
- NinePointTwo Capital's Cardlytics position peaked at $290K in Q3 2022.
- 121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.
Based on NinePointTwo Capital's 13F filing for Q4 2022, filed 14 Feb 2023.